Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Johansson

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|April 27, 2026
Recurrence Rate After Post-Operative Two-Hour Continuous Bladder Irrigation for Primary Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort StudyPatrick Sterner, Sanna Gimbergsson, Markus Johansson, et al.
Journal of Personalized Medicine|December 23, 2022
Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential ThromboprophylaxisHarriet Rydell, Anna Ericson, Victoria Eriksson, et al.
Microbial Pathogenesis|October 20, 2022
Sequence-based genotyping of extra-intestinal pathogenic Escherichia coli isolates from patients with suspected community-onset sepsis, SwedenDiana Tilevik, Anna-Karin Pernestig, Magnus Fagerlind, et al.
Biology Open|September 4, 2020
Cardiac hypertrophy in a dish: a human stem cell based modelMarkus Johansson, Benjamin Ulfenborg, Christian X Andersson, et al.
Journal of Personalized Medicine|December 29, 2022
A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients-A Study of a Clinical Multicentre DatabaseVictoria Eriksson, Oscar Holmkvist, Ylva Huge, et al.
Life (Basel, Switzerland)|August 26, 2022
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerHarriet Rydell, Ylva Huge, Victoria Eriksson, et al.
Life (Basel, Switzerland)|February 25, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac HypertrophyMarkus Johansson, Benjamin Ulfenborg, Christian X Andersson, et al.
Translational Andrology and Urology|September 12, 2022
Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical databaseVictoria Eriksson, Jennie Holmlund, Erik Wiberg, et al.
Translational Andrology and Urology|July 21, 2025
Does neoadjuvant chemotherapy and radical cystectomy in muscle-invasive bladder cancer obliterate survival differences between genders?Gina Sidiqi, Hanna Stauch, Markus Johansson, et al.
Journal of Personalized Medicine|September 28, 2023
The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy-A Multicentre Retrospective Cohort StudyEmma Schulz Hägersten, Kristoffer Ottosson, Sofia Pelander, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|April 27, 2026
Recurrence Rate After Post-Operative Two-Hour Continuous Bladder Irrigation for Primary Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort StudyPatrick Sterner, Sanna Gimbergsson, Markus Johansson, et al.
Journal of Personalized Medicine|December 23, 2022
Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential ThromboprophylaxisHarriet Rydell, Anna Ericson, Victoria Eriksson, et al.
Microbial Pathogenesis|October 20, 2022
Sequence-based genotyping of extra-intestinal pathogenic Escherichia coli isolates from patients with suspected community-onset sepsis, SwedenDiana Tilevik, Anna-Karin Pernestig, Magnus Fagerlind, et al.
Biology Open|September 4, 2020
Cardiac hypertrophy in a dish: a human stem cell based modelMarkus Johansson, Benjamin Ulfenborg, Christian X Andersson, et al.
Journal of Personalized Medicine|December 29, 2022
A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients-A Study of a Clinical Multicentre DatabaseVictoria Eriksson, Oscar Holmkvist, Ylva Huge, et al.
Life (Basel, Switzerland)|August 26, 2022
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerHarriet Rydell, Ylva Huge, Victoria Eriksson, et al.
Life (Basel, Switzerland)|February 25, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac HypertrophyMarkus Johansson, Benjamin Ulfenborg, Christian X Andersson, et al.
Translational Andrology and Urology|September 12, 2022
Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical databaseVictoria Eriksson, Jennie Holmlund, Erik Wiberg, et al.
Translational Andrology and Urology|July 21, 2025
Does neoadjuvant chemotherapy and radical cystectomy in muscle-invasive bladder cancer obliterate survival differences between genders?Gina Sidiqi, Hanna Stauch, Markus Johansson, et al.
Journal of Personalized Medicine|September 28, 2023
The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy-A Multicentre Retrospective Cohort StudyEmma Schulz Hägersten, Kristoffer Ottosson, Sofia Pelander, et al.
Pageof 4